BackABVC BioPharma Overview

ABVC BioPharma Long Term Debt

Latest long-term debt for ABVC: $1.4M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$1.41M
693.46% YoYΔ $1.23M vs prior year quarter

Peer trimmed avg / median

Loading

ABVC BioPharma Long Term Debt History

Loading

ABVC BioPharma vs. peers: Long Term Debt Comparison

Loading

ABVC BioPharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ABVC BioPharma (ABVC) FAQ

As of the most recent data (June 2026), ABVC shows a long-term debt of $1.4M. That compares with $180K in the prior-year period — up 693.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ABVC's long-term debt is now $1.4M (was $180K) — a 693.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ABVC BioPharma is outperforming or lagging.

Tracking ABVC's long-term debt over time shows whether ABVC BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4M That compares with $180K in the prior-year period — up 693.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has ABVC BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $1.4M) with ownership activity and broader fundamentals.

ABVC BioPharma's long-term debt is $1.4M; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.